The University of Chicago Header Logo

Connection

Cheng-Kai Kao to Stroke

Back to Details
This is a "connection" page, showing publications Cheng-Kai Kao has written about Stroke.
Cheng-Kai Kao
Connection Strength
0.065
Stroke
  1. Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban). Circulation. 2017 02 14; 135(7):648-655.
    View in: PubMed
    Score: 0.065
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.